Close icon

Personalise what you see on this page.

Choose from the options below. We'll show you information based on your current location as default.

I'M FROM

  • United States
Please select so we can show the most relevant content.

LIVING IN

  • United States
Please select so we can show the most relevant content.

LOOKING FOR

  • Undergraduate courses
Please select so we can show the most relevant content.

Change here for Clearing courses

Viewing as a student from United States living in United States interested in Undergraduate courses

You are looking at:

Courses starting in 2022

OK, GOT IT

Looking for Clearing information?

CHANGE

Cancer and Genetics (PhD, MPhil, MD)

Cardiff University

Add to favourites

Course options

  • Qualification

    PhD/DPhil - Doctor of Philosophy

  • Location

    Cardiff University

  • Study mode

    Full time

  • Start date

    01-OCT-21, 04-JAN-22, 01-APR-22, 01-JUL-22

  • Duration

    3 years

Course summary

Overview

The programme strategy is to drive research for the benefit of patients affected by cancer and by inherited disease in Wales and beyond. The programme of research maps onto the translational research pathway ranging from fundamental science through to pre-clinical testing of new therapeutic agents as well as early and late phase clinical trials. Our translational research focuses on the genetic and molecular basis of human disease within a central theme of cancer. The Division of Cancer and Genetics provides expertise and facilities to conduct research into human genetics and disease, prognostic and diagnostic markers for cancer, novel therapies for solid organ and haematological cancers, metastasis, cancer immunology and cancer cell biology. The programme will lead to a research degree in cancer and / or genetics that could be used in a variety of academic, clinical and industrial settings.

Course structure

Translational research encompassing fundamental biology, applied and clinical research is undertaken in all areas of research. The translational loop is closed by aiming to provide new diagnostics for cancer risk and new cancer therapeutics by facilitating the partnerships between Patient, Scientist, Clinician and Pharma Industries. The areas studied include genome instability (telomere-driven genome instability and DNA damage and repair), the molecular genetics of cancer and inherited tumour predisposition including tuberous sclerosis and Rett syndrome. Solid cancer research includes prostate, bladder, breast, colorectal and head and neck whilst non-solid cancer research encompasses haematological malignancies such as acute myeloid leukaemia (AML), chronic lymphocytic leukaemia (CLL) and other lymphoid malignancies, myeloma and clinical stem cell transplantation. The underlying science is multidisciplinary including imaging, cell and molecular biology as well cross-cutting themes with immunology and pharmacy. In all cases, designing and delivering multi-centre late-phase clinical trials and associated translational research in various solid cancers and haematological malignancies is a significant area of research within the Division. Here the development of therapies designed for specific individuals with specific cancers is an objective.

Tuition fees

Students living in United States
(international fees)

Information not available

Please check with the institution for most up to date details.

University information

Cardiff University

  • University League Table

    25th

  • Campus address

    Cardiff University, PO Box 921, Cardiff, Cardiff, CF10 3XQ, Wales

Cardiff University has a welcoming and vibrant international community, with over 8,600 students coming from more than 130 countries.
Cardiff is a truly global institution, with more than 200 partnerships and formal research links worldwide giving its students access to unique opportunities.
In addition to a wide range of support services, your studies will be guided by a personal tutor able to give you both academic and professional advice.

Subject rankings

  • Subject ranking

    36th out of 100 11

    15th out of 35 3

  • Entry standards

    / Max 240
    143 65%

    28th

    1
  • Graduate prospects

    / Max 100
    76.0 76%

    33rd

    36
  • Student satisfaction

    / Max 5
    3.87 77%

    91st

    5
  • Entry standards

    / Max 239
    184 76%

    12th

    3
  • Graduate prospects

    / Max 100
    100.0 100%

    1st

  • Student satisfaction

    / Max 5
    4.11 82%

    19th

    5

Is this page useful?

Yes No

Sorry about that...

HOW CAN WE IMPROVE IT?

SUBMIT

Thanks for your feedback!